http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2586283-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e7b191909a14dc4b3a56531180a70ff |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16 |
| filingDate | 2014-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68162a01268879c414ed18dfd232f42d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_757a86397619489148908f919ee503df http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a3967a2aed0893dfd31e571bfcf93e1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ad0cb5a923df9c57941d0ea3516ca2c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4dd47d02686a8b54e76aa3efa4cd00e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fab3128d0badd78de7939625ee531c3 |
| publicationDate | 2016-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2586283-C1 |
| titleOfInvention | INJECTION OR INFUSION SOLUTION OF L-ARGININE SALT OF 5-METHYL-6-NITRO-1,2,4-TRIAZOLO[1,5-a] PYRIMIDIN-7-ONE MONOHYDRATE FOR THERAPY OF INFLUENZA AND OTHER VIRAL INFECTIONS |
| abstract | FIELD: medicine. n SUBSTANCE: disclosed are compositions for injection and infusion solutions of antiviral preparation wide range of action - L-arginine salt of 5-methyl-6-nitro-1,2,4-triazolo[1,5-a]pyrimidin-7-one monohydrate, including auxiliary components. Infusion and injection solutions of L-arginine salt of 5-methyl-6-nitro-1,2,4-triazolo[1,5-a]pyrimidin-7-one monohydrate are based on use of solubilisers of Glutamine type, which increases solubility of main medicinal component and its bioavailability in tissues in a vascular bed. Introduction of Glutathione and Carnosine is linked with their ability to stabilise cell metabolism of Z-arginine salt of 5-methyl-6-nitro-1,2,4-triazolo[1,5-a]pyrimidin-7-one monohydrate and increasing viability of infected cells. n EFFECT: injection and infusion forms of antiviral preparation based on L-arginine salt of 5-methyl-6-nitro-1,2,4-triazolo[1,5-a]pyrimidin-7-one monohydrate are intended for treating severe forms of viral infections in accordance with pharmacological profile of antiviral activity and primarily complicated by influenza. n 2 cl, 2 ex, 2 tbl, 1 dwg |
| priorityDate | 2014-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 83.